These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30415025)

  • 41. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of dementia and Alzheimer's disease in elders of nursing homes and a senior center of Durango City, Mexico.
    Alvarado-Esquivel C; Hernández-Alvarado AB; Tapia-Rodríguez RO; Guerrero-Iturbe A; Rodríguez-Corral K; Martínez SE
    BMC Psychiatry; 2004 Feb; 4():3. PubMed ID: 15070420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
    Fanouriakis A; Mastorodemos V; Pamfil C; Papadaki E; Sidiropoulos P; Plaitakis A; Amoiridis G; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2014 Jun; 43(6):751-8. PubMed ID: 24332007
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study.
    Roshanisefat H; Bahmanyar S; Hillert J; Olsson T; Montgomery S
    Eur J Neurol; 2014 Nov; 21(11):1353-e88. PubMed ID: 25041631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis.
    Roe CM; Xiong C; Miller JP; Morris JC
    Neurology; 2007 Jan; 68(3):223-8. PubMed ID: 17224578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease.
    Piguet O; Halliday GM; Creasey H; Broe GA; Kril JJ
    Int Psychogeriatr; 2009 Aug; 21(4):688-95. PubMed ID: 19493380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and incidence of Alzheimer's disease in Europe: A meta-analysis.
    Niu H; Álvarez-Álvarez I; Guillén-Grima F; Aguinaga-Ontoso I
    Neurologia; 2017 Oct; 32(8):523-532. PubMed ID: 27130306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Living Alone with Alzheimer's Disease: Data from SveDem, the Swedish Dementia Registry.
    Cermakova P; Nelson M; Secnik J; Garcia-Ptacek S; Johnell K; Fastbom J; Kilander L; Winblad B; Eriksdotter M; Religa D
    J Alzheimers Dis; 2017; 58(4):1265-1272. PubMed ID: 28550260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ambiguous relationships between aging and Alzheimer's disease: a critical literature review.
    Scodellaro C; Pin S
    Dementia (London); 2013 Jan; 12(1):137-51. PubMed ID: 24336668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
    Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.
    Borjabad A; Volsky DJ
    J Neuroimmune Pharmacol; 2012 Dec; 7(4):914-26. PubMed ID: 23065460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alzheimer's disease. AMA Council on Scientific Affairs Reference Committee D.
    J Okla State Med Assoc; 1998 Aug; 91(5):298-306. PubMed ID: 9714972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive Decline in Older People with Multiple Sclerosis-A Narrative Review of the Literature.
    Chiang HS; Khera A; Stopschinski BE; Stuve O; Hart J; Kelley B; Nguyen T
    Geriatrics (Basel); 2022 Jun; 7(3):. PubMed ID: 35735766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Cross Talk between Underlying Mechanisms of Multiple Sclerosis and Epilepsy May Provide New Insights for More Efficient Therapies.
    Rayatpour A; Farhangi S; Verdaguer E; Olloquequi J; Ureña J; Auladell C; Javan M
    Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681255
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards a Consensus on Alzheimer's Disease Comorbidity?
    Avitan I; Halperin Y; Saha T; Bloch N; Atrahimovich D; Polis B; Samson AO; Braitbard O
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Inverse Comorbidity between Alzheimer's Disease and Lung Cancer: New Insights from Matrix Factorization.
    Greco A; Sanchez Valle J; Pancaldi V; Baudot A; Barillot E; Caselle M; Valencia A; Zinovyev A; Cantini L
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31247897
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging T cell immunoregulatory mechanisms in multiple sclerosis and Alzheimer's disease.
    Hawiger D
    Front Aging Neurosci; 2024; 16():1350240. PubMed ID: 38435400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Natural Polysaccharides Alleviate Neurological Disorders: New Updates.
    AlMatar M; Makky EA; Ramli ANM
    Mini Rev Med Chem; 2022; 22(22):2813-2819. PubMed ID: 35319363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.